Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 16, 2026.
|Slideshows|November 2, 2017
Virtual Housecalls for Patients With Parkinson’s?
Author(s)Veronica Hackethal, MD
Advertisement
Virtual housecalls to patients with Parkinson's disease are not only feasible and efficient, but patients appear to like them. Details from a national study tell the story here.
References:
1. Dorsey ER, George BP, Leff B, Willis AW. The coming crisis: obtaining care for the growing burden of neurodegenerative conditions. Neurology. 2013;80:1989â1996.2. Wootton R. Twenty years of telemedicine in chronic disease management--an evidence synthesis. J Telemed Telecare. 2012;18:211-220.3. Beck CA, Beran DB, Biglan KM, et al. National randomized controlled trial of virtual house calls for Parkinson disease. Neurology. 2017;12;89:1152-1161.
Advertisement
Related to this article
A quick-read roundup of 10 late-breaking abstracts from the 2026 MDS Congress, from phase 3 Parkinson disease readouts to long-term data in Huntington disease and Tourette syndrome, with the key results that matter for practice.
The Galassia trial will evaluate the safety and tolerability of intranasal cenegermin in about 60 children with spastic cerebral palsy across Italy.
The director of the Center for Neurological Restoration at Cleveland Clinic discusses when to transition beyond oral medication and considerations for selecting device-aided therapies in PD.
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Accepts Troriluzole NDA Resubmission for Spinocerebellar Ataxia
2
Real-World Data Show Switch to Subcutaneous Ocrelizumab Well Tolerated
3
Advances in Spinal Cord MRI for Multiple Sclerosis: Julien Cohen-Adad, PhD
4
CALLIPER Extension Data Show Sustained Disability Outcomes With Vidofludimus Calcium in Progressive MS
5